Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

View All Documentation

EHU015351

Sigma-Aldrich

MISSION® esiRNA

targeting human AIM2

Sign Into View Organizational & Contract Pricing

Select a Size

S614513-1G
SGD 294.00

SGD 294.00

Estimated to ship onMay 02, 2025Details

All Photos(1)

Select a Size

Change View
S614513-1G
SGD 294.00

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

SGD 294.00

Estimated to ship onMay 02, 2025Details

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

CGGTGTCTGCAGTGATGAAGACCATTCGTATTTTTCAGAAGTTGAATTATATGCTTTTGGCAAAACGTCTTCAGGAGGAGAAGGAGAAAGTTGATAAGCAATACAAATCGGTAACAAAACCAAAGCCACTAAGTCAAGCTGAAATGAGTCCTGCTGCATCTGCAGCCATCAGAAATGATGTCGCAAAGCAACGTGCTGCACCAAAAGTCTCTCCTCATGTTAAGCCTGAACAGAAACAGATGGTGGCCCAGCAGGAATCTATCAGAGAAGGGTTTCAGAAGCGCTGTTTGCCAGTTATGGTACTGAAAGCAAAGAAGCCCTTCACGTTTGAGACCCAAGAAGGCAAGCAGGAGATGTTTCATGCTACAGTGGCTACAGAAAAGGAATTCTTCTTTGTAAAAGTTTTTAATACACTGCTGAAAGATAAATTCATTCCAAAGAGAATAATTATAATAGCAAGATATTATCGGCACAGTGGTTTCTTAGAGGTAAATAGCGCCTCACGTGTG

Ensembl | human accession no.

ENSG00000163568

NCBI accession no.

NM_004833

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... AIM2(9447) , AIM2(9447)

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
EHU137161EHU106471EHU143921
MISSION® esiRNA targeting human AIM2

EHU015351

MISSION® esiRNA

MISSION® esiRNA targeting human ECEL1

EHU137161

MISSION® esiRNA

MISSION® esiRNA targeting human GSTO1

EHU106471

MISSION® esiRNA

MISSION® esiRNA targeting human MED26

EHU143921

MISSION® esiRNA

Gene Information

human ... AIM2(9447), AIM2(9447)

Gene Information

human ... ECEL1(9427), ECEL1(9427)

Gene Information

human ... GSTO1(9446), GSTO1(9446)

Gene Information

human ... MED26(9441), MED26(9441)

product line

MISSION®

product line

MISSION®

product line

MISSION®

product line

MISSION®

esiRNA cDNA target sequence

CGGTGTCTGCAGTGATGAAGACCATTCGTATTTTTCAGAAGTTGAATTATATGCTTTTGGCAAAACGTCTTCAGGAGGAGAAGGAGAAAGTTGATAAGCAATACAAATCGGTAACAAAACCAAAGCCACTAAGTCAAGCTGAAATGAGTCCTGCTGCATCTGCAGCCATCAGAAATGATGTCGCAAAGCAACGTGCTGCACCAAAAGTCTCTCCTCATGTTAAGCCTGAACAGAAACAGATGGTGGCCCAGCAGGAATCTATCAGAGAAGGGTTTCAGAAGCGCTGTTTGCCAGTTATGGTACTGAAAGCAAAGAAGCCCTTCACGTTTGAGACCCAAGAAGGCAAGCAGGAGATGTTTCATGCTACAGTGGCTACAGAAAAGGAATTCTTCTTTGTAAAAGTTTTTAATACACTGCTGAAAGATAAATTCATTCCAAAGAGAATAATTATAATAGCAAGATATTATCGGCACAGTGGTTTCTTAGAGGTAAATAGCGCCTCACGTGTG

esiRNA cDNA target sequence

GCAGCAGCTAGTGGAAGACATCAAGTACATCCTGGGCCAGCGCCTGGAGGAGCTGGACTGGATGGACGCCGAGACCAGGGCTGCTGCTCGGGCCAAGCTCCAGTACATGATGGTGATGGTCGGCTACCCGGACTTCCTGCTGAAACCCGATGCTGTGGACAAGGAGTATGAGTTTGAGGTCCATGAGAAGACCTACTTCAAGAACATCTTGAACAGCATCCGCTTCAGCATCCAGCTCTCAGTTAAGAAGATTCGGCAGGAGGTGGACAAGTCCACGTGGCTGCTCCCCCCACAGGCGCTCAATGCCTACTATCTACCCAACAAGAACCAGATGGTGTTCCCCGCGGGCATCCTGCAGCCCACCCTGTACGACCCTGACTTCCCACAGTCTCTCAACTACGGGGGCATCGGCACCATCATTGGACATGAGCTG

esiRNA cDNA target sequence

GGACGCGTCTAGTCCTGAAGGCCAAGGGAATCAGGCATGAAGTCATCAATATCAACCTGAAAAATAAGCCTGAGTGGTTCTTTAAGAAAAATCCCTTTGGTCTGGTGCCAGTTCTGGAAAACAGTCAGGGTCAGCTGATCTACGAGTCTGCCATCACCTGTGAGTACCTGGATGAAGCATACCCAGGGAAGAAGCTGTTGCCGGATGACCCCTATGAGAAAGCTTGCCAGAAGATGATCTTAGAGTTGTTTTCTAAGGTGCCATCCTTGGTAGGAAGCTTTATTAGAAGCCAAAATAAAGAAGACTATGCTGGCCTAAAAGAAGAATTTCGTAAAGAATTTACCAAGCTAGAGGAGGTTCTGACTAATAAGAAGACGACCTTCTTTGGTGGCAATTCTATCTCTATGATTGATTACCTCATCTGGCCC

esiRNA cDNA target sequence

GTCAAGCCTGTCCGGTTAAAAGAGCGGAAGCTCACCTTTGACCCCATGACGAGACAGATCAAACCTCTGACCCAGAAAGAGCCAGTGCGGGCAGACAGCCCTGTGCACATGGAGCAGCAGTCCAGGACAGAGCTGGACAAGCAGGAGGCCAAGGCCAGCCTCCAGAGCCCCTTCGAACAGACGAACTGGAAGGAGCTGTCACGCAACGAGATCATCCAGTCCTACCTGAGCCGGCAGAGCAGCCTGCTCTCATCATCGGGCGCGCAGACCCCAGGGGCTCACCACTTCATGTCTGAGTACCTGAAGCAGGAGGAGAGCACCCGGCAAGGGGCCAGGCAGCTGCATGTGCTGGTGCCTCAAAGCCCGCCCACGGACCTCCCTGGTCTGACCCGGGAGGTCACACAGGACGATCTCGACAGA

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

NCBI accession no.

NM_004833

NCBI accession no.

NM_004826

NCBI accession no.

NM_004832

NCBI accession no.

NM_004831

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

12 - Non Combustible Liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    OZT
    LZT
    RFT
    SAT
    VHS

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    N Yoon et al.
    Cell death & disease, 7, e2191-e2191 (2016-04-15)
    Our recent study showed that human mesenchymal stem/stromal cells (hMSCs) are activated to express tumor necrosis factor (TNF)-α-related apoptosis-inducing ligand (TRAIL) by exposure to TNF-α and these activated hMSCs effectively induce apoptosis in triple-negative breast cancer MDA-MB-231 (MDA) cells in
    Minda Zhang et al.
    Journal of cellular physiology, 234(11), 20161-20173 (2019-04-07)
    The human absent in melanoma 2 (AIM2) is considered as a DNA recognizer. AIM2 has been described as a tumor suppressor gene in the early years. But recent studies suggested that it functions as an oncogene in several cancers. However
    Yunjia Yang et al.
    Journal of cellular biochemistry, 120(10), 17744-17756 (2019-06-19)
    Absent in melanoma 2 (AIM2) is a critical component in natural immunity system and is closely related to cancer initiation and development. It has been shown that AIM2 inhibited colorectal cancer (CRC) development and cell proliferation. It remains unresolved how
    Ying Xu et al.
    Oncotarget, 8(49), 86339-86355 (2017-11-22)
    Hepatic ischemia/reperfusion (I/R) contributes to major complications in clinical practice affecting perioperative morbidity and mortality. Recent evidence suggests the key role of nucleotide-binding oligomerization domain-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) inflammaosme activation on the pathogenesis of I/R injury.
    Mehdi Farshchian et al.
    Oncotarget, 8(28), 45825-45836 (2017-05-21)
    Cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer. Inflammation is a typical feature in cSCC progression. Analysis of the expression of inflammasome components in cSCC cell lines and normal human epidermal keratinocytes revealed upregulation of the
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service